These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11367654)

  • 1. [Effect of 764-3 on ventricular collagen deposition in pulmonary hypertension induced by chronic hypoxia and monocrotaline in rats].
    Liu Z; Cheng X; Cai R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Feb; 18(2):97-100. PubMed ID: 11367654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of an extract of salviae miltiorrhizae (764-3) on structural remodeling of intra-acinar pulmonary artery in pulmonary hypertension due to chronic hypoxia and monocrotaline in rats].
    Liu Z; Cheng X; Cai R
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):358-60. PubMed ID: 11326894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of 764-3 on collagen deposition in hypertensive pulmonary arteries in hypoxic rats].
    Liu Z; Cheng X; Cai R; Sun B; Zhu Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):197-202. PubMed ID: 11367705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.
    Pereira SL; Kummerle AE; Fraga CA; Barreiro EJ; Rocha Nde N; Ferraz EB; do Nascimento JH; Sudo RT; Zapata-Sudo G
    Eur J Pharmacol; 2013 Feb; 702(1-3):316-22. PubMed ID: 23399770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway.
    Rajabi S; Najafipour H; Jafarinejad Farsangi S; Joukar S; Beik A; Iranpour M; Kordestani Z
    BMC Complement Med Ther; 2020 Jul; 20(1):218. PubMed ID: 32660602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension.
    Yavuz T; Uzun O; Macit A; Comunoglu C; Yavuz O; Silan C; Yuksel H; Yildirim HA
    Pathol Res Pract; 2013 May; 209(5):302-8. PubMed ID: 23582365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TNF-alpha blockade in monocrotaline-induced pulmonary hypertension.
    Henriques-Coelho T; Brandão-Nogueira A; Moreira-Gonçalves D; Correia-Pinto J; Leite-Moreira AF
    Rev Port Cardiol; 2008 Mar; 27(3):341-8. PubMed ID: 18551920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of γ-aminobutyric acid on right ventricular pressure and pulmonary vascular remodeling in experimental pulmonary hypertension.
    Suzuki R; Maehara R; Kobuchi S; Tanaka R; Ohkita M; Matsumura Y
    Life Sci; 2012 Oct; 91(13-14):693-8. PubMed ID: 22542556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat.
    Zhang TT; Cui B; Dai DZ
    Acta Pharmacol Sin; 2004 Feb; 25(2):226-30. PubMed ID: 14769214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The intervention of ginkgo biloba extract on monocrotaline-induced right ventricular hypertrophy in rats and its mechanism].
    Chen HQ; Cai KF
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Feb; 35(2):169-172. PubMed ID: 31250611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventive effects of tetrandrine on pulmonary hypertension and right ventricular hypertrophy in rats induced by monocrotaline].
    Jin X; Zhang X; Xing J; Liu K; Wang H
    Zhongguo Zhong Yao Za Zhi; 1996 Dec; 21(12):751-2, 763. PubMed ID: 9812685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats.
    Lamberts RR; Caldenhoven E; Lansink M; Witte G; Vaessen RJ; St Cyr JA; Stienen GJ
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1869-76. PubMed ID: 17604325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy.
    Tanaka K; Honda M; Kuramochi T; Hashimoto M; Masumura S; Mansoor AM; Ishikawa S; Morioka S
    J Hypertens; 1994 Oct; 12(10):1147-54. PubMed ID: 7836730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.